Share this:

Washington, DC – The Board of Pharmacy Specialties (BPS) has approved a role delineation study (RDS) in Pain Management Pharmacy for 2020-2021. Conducting an RDS is a critical step in evaluating the appropriateness and feasibility of developing a proposed certification for a given specialty. The purpose of the role delineation study is to determine whether this practice area is based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in the proposed specialty. BPS will appoint approximately 15 individuals with expertise in pain management pharmacy to oversee the RDS, in partnership with BPS Psychometric Staff, for the proposed specialty in Pain Management. 


Individuals actively engaged in pain management pharmacy, wishing to be considered for appointment to the Pain Management Pharmacy Role Delineation Study Taskforce should apply using the link below by 5 pm EST on October 8, 2020. BPS will make appointments by October 20, 2020 and the taskforce will convene for an initial virtual meeting in early November (schedule TBD). 


Expectations for participation will include attendance and engaged contribution on multiple (at least 5) virtual meetings, as well as a possible face-to-face meeting in 2021 (provided the COVID-19 pandemic conditions permit it).


Apply for the Panel Here:


The initial work of the taskforce – a draft inventory of Performance Domains as well as subsidiary tasks and knowledge areas crucial to the role – will then be validated via a survey administered to pharmacists practicing in the area. If the RDS yields information suggesting that Pain Management Pharmacy should be considered as a specialty practice in pharmacy, BPS will then issue a call to the profession for a petition for specialty recognition of pain management pharmacy practice.  


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 46,000 pharmacist certifications across 14 specialties.


BPS Media Contact
Alexander Jean-Baptiste
Senior Manager, Social Media & Content Marketing
(202) 760-3836